Researchers have found diffusion-weighted magnetic resonance imaging (DWI) or gadolinium-enhanced T1-weighted volumetric interpolated breath-hold examination (VIBE) sequences are the most efficient MRI sequences for prostate cancer diagnosis, according to new research published online on Oct. 17 in the American Journal of Roentgenology.

A new study found that rates of supplemental screening among black women with dense breasts increased after the passage of statewide mandatory breast density notification laws, according to research published Oct. 18 in the Journal of the American College of Radiology.

At the 60th annual meeting of the American Society for Radiation Oncology (ASTRO), Oct. 21-24 at the Henry B. Gonzalez Convention Center in San Antonio, Siemens Healthineers unveils the MAGNETOM RT Pro edition for MAGNETOM Sola – a version of the company’s new 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) scanner that is designed for assistance in radiation therapy (RT) treatment planning. In addition to BioMatrix technology, which addresses patients’ anatomical and physiological differences to overcome unwanted exam variability, the new scanner includes hardware and software that supports optimal treatment planning.

Continuing its efforts to empower clinicians and patients in their fight against breast cancer, GE Healthcare today launched the Invenia Automated Breast Ultrasound (ABUS) 2.0 in the United States.

A $1.6 million, four-year grant from the National Cancer Institute of the National Institutes of Health (NIH) was awarded to a researcher from Tulane University in Louisiana to develop a prostate cancer scanner that can check whether all traces of cancer have been removed after surgery, according to The Associated Press.

The University of Texas at Arlington (UTA) was awarded U.S. and international patents on a nanoparticle that can be activated by x-ray or ultrasound and kill multiple cancers without harming healthy surrounding tissues.

Results of a new randomized, phase II clinical trial have demonstrated an aggressive form of precision radiation therapy can increase the lifespan of oligometastatic cancer patients and doubles how long they can live without cancer, according to the American Society for Radiation Oncology (ASTRO).

In spite of guidelines recommending against routine x-rays for infants diagnosed with bronchitis, new analysis of emergency department visits in the United States suggests there has been no decrease in x-ray utilization.